Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration

Abstract CRISPR-Cas13 systems have therapeutic promise for the precise correction of point mutations in RNA. Using adenosine deaminase acting on RNA (ADAR) effectors, A-I base conversions can be targeted using guide RNAs (gRNAs). We compare the Cas13 effectors PspCas13b and Cas13bt3 for the repair o...

Full description

Saved in:
Bibliographic Details
Main Authors: Lewis E. Fry, Lauren Major, Ahmed Salman, Lucy A. McDermott, Jun Yang, Andrew J. King, Michelle E. McClements, Robert E. MacLaren
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-025-07557-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861726853988352
author Lewis E. Fry
Lauren Major
Ahmed Salman
Lucy A. McDermott
Jun Yang
Andrew J. King
Michelle E. McClements
Robert E. MacLaren
author_facet Lewis E. Fry
Lauren Major
Ahmed Salman
Lucy A. McDermott
Jun Yang
Andrew J. King
Michelle E. McClements
Robert E. MacLaren
author_sort Lewis E. Fry
collection DOAJ
description Abstract CRISPR-Cas13 systems have therapeutic promise for the precise correction of point mutations in RNA. Using adenosine deaminase acting on RNA (ADAR) effectors, A-I base conversions can be targeted using guide RNAs (gRNAs). We compare the Cas13 effectors PspCas13b and Cas13bt3 for the repair of the gene USH2A, a common cause of inherited retinal disease and Usher syndrome. In cultured cells, we demonstrate up to 80% efficiency for the repair of the common c.11864 G > A and its murine equivalent c.11840 G > A, across different gRNAs and promoters. We develop and characterize a mouse model of Usher syndrome carrying the c.11840 G > A mutation designed for the evaluation of base editors for inherited retinal disease. Finally, we compare Cas13 effectors delivered via AAV for the repair of Ush2a in photoreceptors. Mean RNA editing rates in photoreceptors across different constructs ranged from 0.32% to 2.04%, with greater efficiency in those injected with PspCas13b compared to Cas13bt3 constructs. In mice injected with PspCas13b constructs, usherin protein was successfully restored and correctly localized to the connecting cilium following RNA editing. These results support the development of transcriptome targeting gene editing therapies for retinal disease.
format Article
id doaj-art-6e54696ba33c4ab7949edfbce4c0942d
institution Kabale University
issn 2399-3642
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj-art-6e54696ba33c4ab7949edfbce4c0942d2025-02-09T12:50:22ZengNature PortfolioCommunications Biology2399-36422025-02-018111610.1038/s42003-025-07557-3Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degenerationLewis E. Fry0Lauren Major1Ahmed Salman2Lucy A. McDermott3Jun Yang4Andrew J. King5Michelle E. McClements6Robert E. MacLaren7Nuffield Department of Clinical Neurosciences & NIHR Oxford Biomedical Research Centre, University of OxfordNuffield Department of Clinical Neurosciences & NIHR Oxford Biomedical Research Centre, University of OxfordNuffield Department of Clinical Neurosciences & NIHR Oxford Biomedical Research Centre, University of OxfordNuffield Department of Clinical Neurosciences & NIHR Oxford Biomedical Research Centre, University of OxfordDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of UtahDepartment of Physiology, Anatomy and Genetics, University of OxfordNuffield Department of Clinical Neurosciences & NIHR Oxford Biomedical Research Centre, University of OxfordNuffield Department of Clinical Neurosciences & NIHR Oxford Biomedical Research Centre, University of OxfordAbstract CRISPR-Cas13 systems have therapeutic promise for the precise correction of point mutations in RNA. Using adenosine deaminase acting on RNA (ADAR) effectors, A-I base conversions can be targeted using guide RNAs (gRNAs). We compare the Cas13 effectors PspCas13b and Cas13bt3 for the repair of the gene USH2A, a common cause of inherited retinal disease and Usher syndrome. In cultured cells, we demonstrate up to 80% efficiency for the repair of the common c.11864 G > A and its murine equivalent c.11840 G > A, across different gRNAs and promoters. We develop and characterize a mouse model of Usher syndrome carrying the c.11840 G > A mutation designed for the evaluation of base editors for inherited retinal disease. Finally, we compare Cas13 effectors delivered via AAV for the repair of Ush2a in photoreceptors. Mean RNA editing rates in photoreceptors across different constructs ranged from 0.32% to 2.04%, with greater efficiency in those injected with PspCas13b compared to Cas13bt3 constructs. In mice injected with PspCas13b constructs, usherin protein was successfully restored and correctly localized to the connecting cilium following RNA editing. These results support the development of transcriptome targeting gene editing therapies for retinal disease.https://doi.org/10.1038/s42003-025-07557-3
spellingShingle Lewis E. Fry
Lauren Major
Ahmed Salman
Lucy A. McDermott
Jun Yang
Andrew J. King
Michelle E. McClements
Robert E. MacLaren
Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration
Communications Biology
title Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration
title_full Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration
title_fullStr Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration
title_full_unstemmed Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration
title_short Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration
title_sort comparison of crispr cas13b rna base editing approaches for ush2a associated inherited retinal degeneration
url https://doi.org/10.1038/s42003-025-07557-3
work_keys_str_mv AT lewisefry comparisonofcrisprcas13brnabaseeditingapproachesforush2aassociatedinheritedretinaldegeneration
AT laurenmajor comparisonofcrisprcas13brnabaseeditingapproachesforush2aassociatedinheritedretinaldegeneration
AT ahmedsalman comparisonofcrisprcas13brnabaseeditingapproachesforush2aassociatedinheritedretinaldegeneration
AT lucyamcdermott comparisonofcrisprcas13brnabaseeditingapproachesforush2aassociatedinheritedretinaldegeneration
AT junyang comparisonofcrisprcas13brnabaseeditingapproachesforush2aassociatedinheritedretinaldegeneration
AT andrewjking comparisonofcrisprcas13brnabaseeditingapproachesforush2aassociatedinheritedretinaldegeneration
AT michelleemcclements comparisonofcrisprcas13brnabaseeditingapproachesforush2aassociatedinheritedretinaldegeneration
AT robertemaclaren comparisonofcrisprcas13brnabaseeditingapproachesforush2aassociatedinheritedretinaldegeneration